DiaMedica Therapeutics Inc.
DMAC
$5.67
-$0.13-2.24%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.78% | -20.19% | -24.74% | -41.72% | -36.44% |
| Total Depreciation and Amortization | 28.57% | 25.93% | 19.23% | 20.00% | 12.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.53% | -59.27% | -64.86% | -65.92% | -57.00% |
| Change in Net Operating Assets | 440.35% | -287.96% | -213.27% | -84.10% | -462.20% |
| Cash from Operations | -10.02% | -29.75% | -59.63% | -62.70% | -53.10% |
| Capital Expenditure | 60.38% | 74.42% | 70.45% | 70.37% | 5.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 148.38% | 186.92% | -239.03% | -257.29% | -980.04% |
| Cash from Investing | 148.14% | 186.40% | -240.29% | -258.60% | -950.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -16.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -67.76% | -68.10% | -- | -- | 27,608.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.77% | -68.13% | 614,133.33% | 614,133.33% | 153,608.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 452.88% | 196.25% | 94.35% | -980.95% | 95.99% |
